nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—Dapsone—malaria	0.193	1	CbGbCtD
Clodronate—SLC25A6—saliva-secreting gland—malaria	0.023	0.0736	CbGeAlD
Clodronate—SLC25A6—hematopoietic system—malaria	0.0219	0.0702	CbGeAlD
Clodronate—SLC25A5—saliva-secreting gland—malaria	0.02	0.064	CbGeAlD
Clodronate—SLC25A5—hematopoietic system—malaria	0.0191	0.0611	CbGeAlD
Clodronate—SLC25A6—kidney—malaria	0.018	0.0576	CbGeAlD
Clodronate—SLC25A5—kidney—malaria	0.0156	0.0501	CbGeAlD
Clodronate—SLC25A6—digestive system—malaria	0.0153	0.0488	CbGeAlD
Clodronate—SLC25A4—kidney—malaria	0.0147	0.0469	CbGeAlD
Clodronate—SLC25A6—blood—malaria	0.0145	0.0465	CbGeAlD
Clodronate—SLC25A6—bone marrow—malaria	0.0141	0.045	CbGeAlD
Clodronate—SLC25A5—digestive system—malaria	0.0133	0.0425	CbGeAlD
Clodronate—SLC25A5—blood—malaria	0.0126	0.0405	CbGeAlD
Clodronate—SLC25A4—digestive system—malaria	0.0124	0.0398	CbGeAlD
Clodronate—SLC25A5—bone marrow—malaria	0.0122	0.0392	CbGeAlD
Clodronate—SLC25A6—liver—malaria	0.0114	0.0364	CbGeAlD
Clodronate—SLC25A5—liver—malaria	0.00988	0.0317	CbGeAlD
Clodronate—Local reaction—Clindamycin—malaria	0.00956	0.0249	CcSEcCtD
Clodronate—SLC25A5—Integration of energy metabolism—PKLR—malaria	0.00941	0.0849	CbGpPWpGaD
Clodronate—SLC25A4—liver—malaria	0.00926	0.0297	CbGeAlD
Clodronate—SLC25A6—brain—malaria	0.00902	0.0289	CbGeAlD
Clodronate—Gastrointestinal symptom NOS—Clindamycin—malaria	0.009	0.0234	CcSEcCtD
Clodronate—Gastrointestinal symptom NOS—Quinine—malaria	0.00883	0.023	CcSEcCtD
Clodronate—Gastrointestinal symptom NOS—Quinidine—malaria	0.00883	0.023	CcSEcCtD
Clodronate—Gastrointestinal symptom NOS—Quinidine barbiturate—malaria	0.00797	0.0207	CcSEcCtD
Clodronate—Digestion impaired—Clindamycin—malaria	0.00792	0.0206	CcSEcCtD
Clodronate—SLC25A6—Integration of energy metabolism—PKLR—malaria	0.00788	0.0711	CbGpPWpGaD
Clodronate—SLC25A5—brain—malaria	0.00784	0.0251	CbGeAlD
Clodronate—Oliguria—Sulfadiazine—malaria	0.00771	0.0201	CcSEcCtD
Clodronate—SLC25A4—brain—malaria	0.00735	0.0235	CbGeAlD
Clodronate—PTGS2—endothelium—malaria	0.00732	0.0234	CbGeAlD
Clodronate—PTGS2—blood plasma—malaria	0.0065	0.0208	CbGeAlD
Clodronate—Proteinuria—Dapsone—malaria	0.00623	0.0162	CcSEcCtD
Clodronate—SLC25A4—Integration of energy metabolism—PKLR—malaria	0.00615	0.0555	CbGpPWpGaD
Clodronate—Protein urine present—Dapsone—malaria	0.00614	0.016	CcSEcCtD
Clodronate—Proteinuria—Clindamycin—malaria	0.00602	0.0157	CcSEcCtD
Clodronate—Protein urine present—Clindamycin—malaria	0.00594	0.0155	CcSEcCtD
Clodronate—Oliguria—Clindamycin—malaria	0.00574	0.0149	CcSEcCtD
Clodronate—Oliguria—Quinine—malaria	0.00563	0.0147	CcSEcCtD
Clodronate—Oliguria—Quinidine—malaria	0.00563	0.0147	CcSEcCtD
Clodronate—Extravasation—Quinidine barbiturate—malaria	0.00537	0.014	CcSEcCtD
Clodronate—Hypocalcaemia—Quinidine barbiturate—malaria	0.00512	0.0133	CcSEcCtD
Clodronate—Oliguria—Quinidine barbiturate—malaria	0.00508	0.0132	CcSEcCtD
Clodronate—Mediastinal disorder—Proguanil—malaria	0.00484	0.0126	CcSEcCtD
Clodronate—Hepatocellular injury—Quinidine barbiturate—malaria	0.00469	0.0122	CcSEcCtD
Clodronate—Anorexia—Pyrimethamine—malaria	0.00467	0.0122	CcSEcCtD
Clodronate—Decreased appetite—Pyrimethamine—malaria	0.00426	0.0111	CcSEcCtD
Clodronate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.00411	0.0371	CbGpPWpGaD
Clodronate—Renal failure acute—Quinidine—malaria	0.00408	0.0106	CcSEcCtD
Clodronate—Renal failure acute—Quinine—malaria	0.00408	0.0106	CcSEcCtD
Clodronate—Renal impairment—Quinine—malaria	0.00396	0.0103	CcSEcCtD
Clodronate—Renal impairment—Quinidine—malaria	0.00396	0.0103	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00396	0.0103	CcSEcCtD
Clodronate—Skin disorder—Proguanil—malaria	0.00371	0.00965	CcSEcCtD
Clodronate—Renal failure acute—Quinidine barbiturate—malaria	0.00368	0.00958	CcSEcCtD
Clodronate—Anorexia—Proguanil—malaria	0.00364	0.00947	CcSEcCtD
Clodronate—PTGS2—hematopoietic system—malaria	0.00359	0.0115	CbGeAlD
Clodronate—Renal impairment—Quinidine barbiturate—malaria	0.00357	0.0093	CcSEcCtD
Clodronate—Abdominal pain upper—Clindamycin—malaria	0.00351	0.00913	CcSEcCtD
Clodronate—Abdominal pain upper—Quinine—malaria	0.00344	0.00895	CcSEcCtD
Clodronate—Abdominal pain upper—Quinidine—malaria	0.00344	0.00895	CcSEcCtD
Clodronate—Decreased appetite—Proguanil—malaria	0.00332	0.00864	CcSEcCtD
Clodronate—Gastrointestinal disorder—Proguanil—malaria	0.0033	0.00858	CcSEcCtD
Clodronate—Bronchospasm—Quinidine—malaria	0.0032	0.00833	CcSEcCtD
Clodronate—Bronchospasm—Quinine—malaria	0.0032	0.00833	CcSEcCtD
Clodronate—Vomiting—Pyrimethamine—malaria	0.00312	0.00811	CcSEcCtD
Clodronate—Abdominal pain upper—Quinidine barbiturate—malaria	0.00311	0.00808	CcSEcCtD
Clodronate—SLC25A6—Metabolism of proteins—NANP—malaria	0.00305	0.0275	CbGpPWpGaD
Clodronate—Abdominal pain—Proguanil—malaria	0.00302	0.00785	CcSEcCtD
Clodronate—PTGS2—kidney—malaria	0.00294	0.00943	CbGeAlD
Clodronate—Bronchospasm—Quinidine barbiturate—malaria	0.00289	0.00752	CcSEcCtD
Clodronate—Bronchospasm—Pentoxifylline—malaria	0.00289	0.00751	CcSEcCtD
Clodronate—Renal failure—Quinidine—malaria	0.00285	0.00743	CcSEcCtD
Clodronate—Renal failure—Quinine—malaria	0.00285	0.00743	CcSEcCtD
Clodronate—Pharyngitis—Dapsone—malaria	0.00273	0.00709	CcSEcCtD
Clodronate—Diarrhoea—Proguanil—malaria	0.00261	0.0068	CcSEcCtD
Clodronate—Renal failure—Quinidine barbiturate—malaria	0.00258	0.0067	CcSEcCtD
Clodronate—Urinary tract disorder—Quinine—malaria	0.00257	0.0067	CcSEcCtD
Clodronate—Urinary tract disorder—Quinidine—malaria	0.00257	0.0067	CcSEcCtD
Clodronate—Urethral disorder—Quinine—malaria	0.00256	0.00665	CcSEcCtD
Clodronate—Urethral disorder—Quinidine—malaria	0.00256	0.00665	CcSEcCtD
Clodronate—PTGS2—digestive system—malaria	0.0025	0.008	CbGeAlD
Clodronate—Vomiting—Proguanil—malaria	0.00243	0.00632	CcSEcCtD
Clodronate—Anorexia—Sulfadiazine—malaria	0.00242	0.00629	CcSEcCtD
Clodronate—Rash—Proguanil—malaria	0.00241	0.00626	CcSEcCtD
Clodronate—Dermatitis—Proguanil—malaria	0.00241	0.00626	CcSEcCtD
Clodronate—PTGS2—blood—malaria	0.00238	0.00762	CbGeAlD
Clodronate—SLC25A4—Metabolism of proteins—NANP—malaria	0.00238	0.0214	CbGpPWpGaD
Clodronate—Mediastinal disorder—Quinidine—malaria	0.00235	0.00611	CcSEcCtD
Clodronate—Mediastinal disorder—Quinine—malaria	0.00235	0.00611	CcSEcCtD
Clodronate—Urinary tract disorder—Quinidine barbiturate—malaria	0.00232	0.00604	CcSEcCtD
Clodronate—Urethral disorder—Quinidine barbiturate—malaria	0.00231	0.006	CcSEcCtD
Clodronate—PTGS2—bone marrow—malaria	0.0023	0.00738	CbGeAlD
Clodronate—Nausea—Proguanil—malaria	0.00227	0.0059	CcSEcCtD
Clodronate—Decreased appetite—Sulfadiazine—malaria	0.0022	0.00573	CcSEcCtD
Clodronate—Gastrointestinal disorder—Sulfadiazine—malaria	0.00219	0.00569	CcSEcCtD
Clodronate—Anaemia—Clindamycin—malaria	0.00214	0.00556	CcSEcCtD
Clodronate—Mediastinal disorder—Quinidine barbiturate—malaria	0.00212	0.00552	CcSEcCtD
Clodronate—Angioedema—Quinidine—malaria	0.00207	0.00539	CcSEcCtD
Clodronate—Angioedema—Quinine—malaria	0.00207	0.00539	CcSEcCtD
Clodronate—Urticaria—Sulfadiazine—malaria	0.00201	0.00524	CcSEcCtD
Clodronate—Abdominal pain—Sulfadiazine—malaria	0.002	0.00521	CcSEcCtD
Clodronate—SLC25A5—Host Interactions of HIV factors—CD4—malaria	0.00192	0.0174	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00192	0.00499	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00192	0.00499	CcSEcCtD
Clodronate—Anaemia—Pentoxifylline—malaria	0.00189	0.00492	CcSEcCtD
Clodronate—Angioedema—Quinidine barbiturate—malaria	0.00187	0.00487	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL10—malaria	0.00187	0.0169	CbGpPWpGaD
Clodronate—Angioedema—Pentoxifylline—malaria	0.00187	0.00486	CcSEcCtD
Clodronate—PTGS2—liver—malaria	0.00186	0.00596	CbGeAlD
Clodronate—Skin disorder—Quinidine—malaria	0.0018	0.00468	CcSEcCtD
Clodronate—Skin disorder—Quinine—malaria	0.0018	0.00468	CcSEcCtD
Clodronate—Pruritus—Sulfadiazine—malaria	0.00179	0.00467	CcSEcCtD
Clodronate—Anorexia—Quinine—malaria	0.00177	0.00459	CcSEcCtD
Clodronate—Anorexia—Quinidine—malaria	0.00177	0.00459	CcSEcCtD
Clodronate—Diarrhoea—Sulfadiazine—malaria	0.00173	0.00451	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00173	0.0045	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00173	0.0045	CcSEcCtD
Clodronate—Dyspnoea—Clindamycin—malaria	0.00168	0.00438	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.00167	0.0151	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—DHODH—malaria	0.00167	0.0151	CbGpPWpGaD
Clodronate—Dyspepsia—Clindamycin—malaria	0.00166	0.00432	CcSEcCtD
Clodronate—Infection—Pentoxifylline—malaria	0.00166	0.00431	CcSEcCtD
Clodronate—Dyspnoea—Quinine—malaria	0.00165	0.0043	CcSEcCtD
Clodronate—Dyspnoea—Quinidine—malaria	0.00165	0.0043	CcSEcCtD
Clodronate—Gastrointestinal disorder—Clindamycin—malaria	0.00163	0.00424	CcSEcCtD
Clodronate—Skin disorder—Quinidine barbiturate—malaria	0.00162	0.00422	CcSEcCtD
Clodronate—Skin disorder—Pentoxifylline—malaria	0.00162	0.00422	CcSEcCtD
Clodronate—SLC25A6—Host Interactions of HIV factors—CD4—malaria	0.00161	0.0145	CbGpPWpGaD
Clodronate—Vomiting—Sulfadiazine—malaria	0.00161	0.00419	CcSEcCtD
Clodronate—Decreased appetite—Quinidine—malaria	0.00161	0.00419	CcSEcCtD
Clodronate—Decreased appetite—Quinine—malaria	0.00161	0.00419	CcSEcCtD
Clodronate—PTGS2—S1P1 pathway—KDR—malaria	0.0016	0.0145	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Quinidine—malaria	0.0016	0.00416	CcSEcCtD
Clodronate—Gastrointestinal disorder—Quinine—malaria	0.0016	0.00416	CcSEcCtD
Clodronate—Rash—Sulfadiazine—malaria	0.0016	0.00416	CcSEcCtD
Clodronate—Dermatitis—Sulfadiazine—malaria	0.0016	0.00415	CcSEcCtD
Clodronate—Anorexia—Quinidine barbiturate—malaria	0.00159	0.00414	CcSEcCtD
Clodronate—Anorexia—Pentoxifylline—malaria	0.00159	0.00414	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.00159	0.0143	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.00156	0.0141	CbGpPWpGaD
Clodronate—Abdominal pain—Dapsone—malaria	0.00154	0.00401	CcSEcCtD
Clodronate—Nausea—Sulfadiazine—malaria	0.00151	0.00392	CcSEcCtD
Clodronate—Urticaria—Clindamycin—malaria	0.0015	0.0039	CcSEcCtD
Clodronate—Abdominal pain—Clindamycin—malaria	0.00149	0.00388	CcSEcCtD
Clodronate—Dyspnoea—Quinidine barbiturate—malaria	0.00149	0.00388	CcSEcCtD
Clodronate—Dyspnoea—Pentoxifylline—malaria	0.00149	0.00387	CcSEcCtD
Clodronate—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.00149	0.0134	CbGpPWpGaD
Clodronate—PTGS2—brain—malaria	0.00148	0.00473	CbGeAlD
Clodronate—Urticaria—Quinine—malaria	0.00147	0.00383	CcSEcCtD
Clodronate—Urticaria—Quinidine—malaria	0.00147	0.00383	CcSEcCtD
Clodronate—Dyspepsia—Pentoxifylline—malaria	0.00147	0.00382	CcSEcCtD
Clodronate—Abdominal pain—Quinine—malaria	0.00146	0.00381	CcSEcCtD
Clodronate—Abdominal pain—Quinidine—malaria	0.00146	0.00381	CcSEcCtD
Clodronate—Decreased appetite—Quinidine barbiturate—malaria	0.00145	0.00378	CcSEcCtD
Clodronate—Decreased appetite—Pentoxifylline—malaria	0.00145	0.00377	CcSEcCtD
Clodronate—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00144	0.00375	CcSEcCtD
Clodronate—SLC25A5—Metabolism—SLC4A1—malaria	0.00142	0.0128	CbGpPWpGaD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.00142	0.0128	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—DHODH—malaria	0.0014	0.0126	CbGpPWpGaD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.00138	0.0125	CbGpPWpGaD
Clodronate—Pruritus—Clindamycin—malaria	0.00134	0.00347	CcSEcCtD
Clodronate—SLC25A5—Metabolism—DECR1—malaria	0.00133	0.012	CbGpPWpGaD
Clodronate—Urticaria—Quinidine barbiturate—malaria	0.00133	0.00345	CcSEcCtD
Clodronate—Urticaria—Pentoxifylline—malaria	0.00133	0.00345	CcSEcCtD
Clodronate—Abdominal pain—Quinidine barbiturate—malaria	0.00132	0.00344	CcSEcCtD
Clodronate—Abdominal pain—Pentoxifylline—malaria	0.00132	0.00343	CcSEcCtD
Clodronate—Pruritus—Quinidine—malaria	0.00131	0.00341	CcSEcCtD
Clodronate—Pruritus—Quinine—malaria	0.00131	0.00341	CcSEcCtD
Clodronate—Diarrhoea—Clindamycin—malaria	0.00129	0.00336	CcSEcCtD
Clodronate—SLC25A5—Disease—PKLR—malaria	0.00128	0.0116	CbGpPWpGaD
Clodronate—Diarrhoea—Quinine—malaria	0.00127	0.0033	CcSEcCtD
Clodronate—Diarrhoea—Quinidine—malaria	0.00127	0.0033	CcSEcCtD
Clodronate—SLC25A4—Host Interactions of HIV factors—CD4—malaria	0.00126	0.0114	CbGpPWpGaD
Clodronate—SLC25A5—HIV Infection—CD4—malaria	0.00125	0.0113	CbGpPWpGaD
Clodronate—Vomiting—Dapsone—malaria	0.00124	0.00323	CcSEcCtD
Clodronate—SLC25A5—Metabolism—HBB—malaria	0.00121	0.0109	CbGpPWpGaD
Clodronate—Vomiting—Clindamycin—malaria	0.0012	0.00312	CcSEcCtD
Clodronate—Rash—Clindamycin—malaria	0.00119	0.0031	CcSEcCtD
Clodronate—SLC25A6—Metabolism—SLC4A1—malaria	0.00119	0.0107	CbGpPWpGaD
Clodronate—Dermatitis—Clindamycin—malaria	0.00119	0.00309	CcSEcCtD
Clodronate—Pruritus—Quinidine barbiturate—malaria	0.00118	0.00308	CcSEcCtD
Clodronate—Pruritus—Pentoxifylline—malaria	0.00118	0.00307	CcSEcCtD
Clodronate—Vomiting—Quinidine—malaria	0.00118	0.00306	CcSEcCtD
Clodronate—Vomiting—Quinine—malaria	0.00118	0.00306	CcSEcCtD
Clodronate—Rash—Quinidine—malaria	0.00117	0.00304	CcSEcCtD
Clodronate—Rash—Quinine—malaria	0.00117	0.00304	CcSEcCtD
Clodronate—Dermatitis—Quinine—malaria	0.00117	0.00304	CcSEcCtD
Clodronate—Dermatitis—Quinidine—malaria	0.00117	0.00304	CcSEcCtD
Clodronate—Nausea—Dapsone—malaria	0.00116	0.00302	CcSEcCtD
Clodronate—SLC25A5—Disease—G6PD—malaria	0.00114	0.0103	CbGpPWpGaD
Clodronate—Diarrhoea—Quinidine barbiturate—malaria	0.00114	0.00298	CcSEcCtD
Clodronate—Diarrhoea—Pentoxifylline—malaria	0.00114	0.00297	CcSEcCtD
Clodronate—Nausea—Clindamycin—malaria	0.00112	0.00292	CcSEcCtD
Clodronate—SLC25A6—Metabolism—DECR1—malaria	0.00112	0.0101	CbGpPWpGaD
Clodronate—Nausea—Quinidine—malaria	0.0011	0.00286	CcSEcCtD
Clodronate—Nausea—Quinine—malaria	0.0011	0.00286	CcSEcCtD
Clodronate—SLC25A4—Metabolism—DHODH—malaria	0.00109	0.00985	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PKLR—malaria	0.00108	0.00971	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PKLR—malaria	0.00108	0.00971	CbGpPWpGaD
Clodronate—Vomiting—Quinidine barbiturate—malaria	0.00106	0.00276	CcSEcCtD
Clodronate—Vomiting—Pentoxifylline—malaria	0.00106	0.00276	CcSEcCtD
Clodronate—Rash—Quinidine barbiturate—malaria	0.00105	0.00274	CcSEcCtD
Clodronate—Dermatitis—Quinidine barbiturate—malaria	0.00105	0.00274	CcSEcCtD
Clodronate—Rash—Pentoxifylline—malaria	0.00105	0.00274	CcSEcCtD
Clodronate—Dermatitis—Pentoxifylline—malaria	0.00105	0.00273	CcSEcCtD
Clodronate—SLC25A6—HIV Infection—CD4—malaria	0.00105	0.00945	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—HBB—malaria	0.00101	0.00912	CbGpPWpGaD
Clodronate—Nausea—Quinidine barbiturate—malaria	0.000993	0.00258	CcSEcCtD
Clodronate—Nausea—Pentoxifylline—malaria	0.000991	0.00258	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1B—malaria	0.00098	0.00884	CbGpPWpGaD
Clodronate—SLC25A6—Disease—G6PD—malaria	0.000959	0.00866	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—G6PD—malaria	0.000959	0.00865	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000936	0.00845	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—SLC4A1—malaria	0.000929	0.00838	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000918	0.00828	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000915	0.00826	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PKLR—malaria	0.000901	0.00813	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000893	0.00806	CbGpPWpGaD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000885	0.00798	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—DECR1—malaria	0.000873	0.00788	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000868	0.00783	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PKLR—malaria	0.00084	0.00758	CbGpPWpGaD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000835	0.00753	CbGpPWpGaD
Clodronate—SLC25A4—HIV Infection—CD4—malaria	0.000818	0.00738	CbGpPWpGaD
Clodronate—SLC25A5—Disease—DHFR—malaria	0.00081	0.00731	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—G6PD—malaria	0.000803	0.00725	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—HBB—malaria	0.000789	0.00712	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.000758	0.00684	CbGpPWpGaD
Clodronate—SLC25A4—Disease—G6PD—malaria	0.000749	0.00676	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000748	0.00674	CbGpPWpGaD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000742	0.00669	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—HPGDS—malaria	0.000731	0.0066	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—malaria	0.000711	0.00642	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PKLR—malaria	0.000704	0.00635	CbGpPWpGaD
Clodronate—SLC25A6—Disease—DHFR—malaria	0.000679	0.00612	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—DHFR—malaria	0.000678	0.00612	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—SCARB1—malaria	0.000671	0.00606	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—G6PD—malaria	0.000627	0.00566	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—HPGDS—malaria	0.000613	0.00553	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000611	0.00552	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6—malaria	0.000574	0.00518	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—DHFR—malaria	0.000568	0.00513	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—SCARB1—malaria	0.000563	0.00508	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.00054	0.00487	CbGpPWpGaD
Clodronate—SLC25A4—Disease—DHFR—malaria	0.00053	0.00478	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000509	0.00459	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CRP—malaria	0.000491	0.00443	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.00048	0.00433	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—HPGDS—malaria	0.000478	0.00432	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	0.000451	0.00407	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL4—malaria	0.000449	0.00405	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—DHFR—malaria	0.000444	0.004	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—SCARB1—malaria	0.000439	0.00396	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CD36—malaria	0.000421	0.0038	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS2—malaria	0.000414	0.00373	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000388	0.0035	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	0.000373	0.00337	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TLR4—malaria	0.000372	0.00336	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—ICAM1—malaria	0.000357	0.00322	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NOS2—malaria	0.000354	0.00319	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CD36—malaria	0.000353	0.00319	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	0.000349	0.00315	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS2—malaria	0.000347	0.00313	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CD4—malaria	0.000344	0.00311	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IFNG—malaria	0.000343	0.0031	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CD4—malaria	0.000306	0.00276	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—malaria	0.000306	0.00276	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000282	0.00254	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CD36—malaria	0.000276	0.00249	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IFNG—malaria	0.000272	0.00245	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS2—malaria	0.000271	0.00244	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CD4—malaria	0.000257	0.00232	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—malaria	0.000242	0.00219	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL2—malaria	0.000241	0.00218	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—malaria	0.000222	0.00201	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DHODH—malaria	0.000216	0.00195	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000212	0.00192	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CD4—malaria	0.0002	0.00181	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000195	0.00176	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC4A1—malaria	0.000184	0.00166	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—malaria	0.000179	0.00162	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—malaria	0.000176	0.00159	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DECR1—malaria	0.000173	0.00156	CbGpPWpGaD
Clodronate—PTGS2—Disease—PKLR—malaria	0.000166	0.0015	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—malaria	0.000166	0.00149	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HBB—malaria	0.000156	0.00141	CbGpPWpGaD
Clodronate—PTGS2—Disease—G6PD—malaria	0.000148	0.00134	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—malaria	0.000142	0.00128	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PKLR—malaria	0.000139	0.00126	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—malaria	0.000139	0.00125	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—G6PD—malaria	0.000124	0.00112	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	0.000122	0.0011	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.00012	0.00108	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—malaria	0.000108	0.000978	CbGpPWpGaD
Clodronate—PTGS2—Disease—DHFR—malaria	0.000105	0.000945	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HPGDS—malaria	9.46e-05	0.000853	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DHFR—malaria	8.77e-05	0.000792	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SCARB1—malaria	8.68e-05	0.000783	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CD36—malaria	5.45e-05	0.000492	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—malaria	5.35e-05	0.000483	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD4—malaria	3.96e-05	0.000357	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—malaria	2.14e-05	0.000193	CbGpPWpGaD
